Асосий контентга ўтиш
AkademIndex

Маҳсулотлар

Ишлаб чиқувчилар учун

AkademBaseЭкотизим учун очиқ API

Dilyara Nabirova

6 та иш

Central Asia Field Epidemiology Training Program

  1. Prevalence of hepatitis B surface antibody among previously vaccinated healthcare workers in Tashkent, Uzbekistan

    Rafail Ibragimov, Dilyara Nabirova, Alfiya Denebaeva +2

    МақолаHepatitis B Virus StudiesHuman Vaccines & Immunotherapeutics20241 иқтибос
    ABI

  2. Treatment Outcomes of Isoniazid-Resistant (Rifampicin Susceptible) Tuberculosis Patients in Uzbekistan, 2017–2018

    Zayniddin Sayfutdinov, Ajay Kumar, Dilyara Nabirova +5

    МақолаTuberculosis Research and EpidemiologyInternational Journal of Environmental Research and Public Health20210 иқтибос
    ABI

  3. Universal Access to Xpert MTB/RIF Testing for Diagnosis of Tuberculosis in Uzbekistan: How Well Are We Doing?

    Laziz Turaev, Ajay Kumar, Dilyara Nabirova +3

    МақолаTuberculosis Research and EpidemiologyInternational Journal of Environmental Research and Public Health20210 иқтибос
    ABI

  4. 1528. Retrospective cohort study of factors associated with non-initiation of antiretroviral therapy among adults newly diagnosed with HIV in Andijan, Uzbekistan, 2018-2021

    Shokhruh Usmanov, Roberta Horth, Alfiya Denebayeva +5

    МақолаHIV, Drug Use, Sexual RiskOpen Forum Infectious Diseases20230 иқтибос
    ABI

  5. 2389. Surveillance evaluation of COVID-19 pharmacovigilance—Karakalpakstan, Uzbekistan, 2022

    Yunis Tursinov, Botirjon Kurbanov, Alfiya Denebayeva +2

    МақолаSARS-CoV-2 and COVID-19 ResearchOpen Forum Infectious Diseases20230 иқтибос
    ABI

  6. COVID-19 vaccination pharmacovigilance in Khojaly district, Uzbekistan: an epidemiological evaluation

    Yunis Tursinov, Roberta Horth, Б. Курбонов +3

    МақолаPharmacovigilance and Adverse Drug ReactionsFrontiers in Public Health20250 иқтибос
    ABI